Neil Gallagher MD

Neil Gallagher, MD PhD, is a Pharma R&D executive with extensive experience in oncology and a strong background in clinical development. Currently, they serve as a Non-Executive Director at Foghorn Therapeutics Inc., Zymeworks Inc., and iOnctura, and as an Advisor to the Board and Chair of the R&D Committee at Nouscom. Previously, Neil held senior positions at Novartis Oncology, Amgen, and AbbVie, where they led the global clinical development of various cancer therapeutics. Currently pursuing a PhD in Cancer Biology from the University of Birmingham and an MD from Trinity College Dublin, they continue to influence the pharmaceutical industry through their leadership and expertise.